Lataa...
Using proteomics as a powerful tool to develop a vaccine against Mediterranean visceral leishmaniasis
Visceral leishmaniasis (VL) is a tropical infectious disease, which is called Mediterranean visceral leishmaniasis (MVL) in the Mediterranean area. In spite of many attempts, no effective commercial vaccine exists for MVL. To find new targets for developing antileishmanial vaccines, knowing parasite...
Tallennettuna:
| Julkaisussa: | J Parasit Dis |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Springer India
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5962495/ https://ncbi.nlm.nih.gov/pubmed/29844618 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12639-018-0986-y |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|